MGNX
MacroGenics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.40
+3.53%Margins
Gross margin
50.4%
EBITDA margin
-48.7%
EBIT margin
-24.3%
Net margin
-8.7%
FCF margin
-39.1%
-34.0%
Return on equity
-4.2%
Return on assets
-52.3%
Return on invested capital
0.60x
Asset turnover
-$63.7M
Cash from operations
$2.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026